Form D · Biotechnology
Vibe Bioscience Ltd.
Calgary, A0 · CIK 0001773208
Offering snapshot reported Apr 9, 2019 · SEC filing
- Reported sold
- $13.9M Offering amount: $13.9M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2019 | Initial | $13,862,093 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336855
Offering amount represents value of common shares issued pursuant to exchange of stock in amalgamation and subsequent share consolidation; Cdn$1.3418=US$1.00
Source: Form D, filed Apr 9, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Arbique | Director |
| Jane Gauthier | Director |
| Raj Kapoor | Director |
| Aaron Katerenchuk | Executive |
| Jim Meloche | Director |
| John Ryan Mercier | Executive |
| Joe Starr | Executive |
| Tyler Townsend | Executive |
| Mark Waldron | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2505 17 Th Avenue Sw, #214
Calgary, A0, T3E 7V3
Calgary, A0, T3E 7V3